Clinical Trials Browser

INDUSTRY × Observational × Hereditary Sensory and Autonomic Neuropathies × Clear all

NCT05868629 2026-04-01

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

Hereditary Sensory and Autonomic Neuropathies

NCT06494540 2026-03-30

NAUTIC

Carcinoma, Non-Small-Cell Lung, Hereditary Sensory and Autonomic Neuropathies

NCT04480814 2025-12-30

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05982886 2023-08-09

Biomarker Testing and Treatment Patterns Among Patients With PIK3CA Mutation in Advanced Breast Cancer

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT04285723 2023-02-09

EPIK-P1

57 enrolled 23 charts 2 FDA

Hereditary Sensory and Autonomic Neuropathies

NCT04425200 2021-12-07

ZENSHIN

Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms